CrossRef Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam Clinical Therapeutics.2022
In addition, for non-dyslipidemic patients the antioxidant enzyme deficiencies were: 33% for atrial flutter, 31% for various combined arrhythmias, 30% for sinus tachycardia, 29% for sinus bradycardia, 28% for ventricular extrasystole, 27% for atrial fibrillation and atrial extrasystole, and 18% for paroxysmal supraventricular tachycardia
Genetics of primary aldosteronism
BMJ 335 , 11071108 (2007)
Each should be managed according to standard clinical guidance, with the reassurance that no special monitoring is required for this combination